Senior Mathematical statisticianOffice of Biostatistics, Center for Drug Evaluation and Research, US FDA, United States
Disclosure information not submitted.
Comparative bleeding risks among NOAC users for nonvalvular atrial fibrillation aged <65 years in the Sentinel System
Wednesday, August 28, 20241:30 PM – 1:45 PM CEST